Recombinant gene containing heat-labile enterotoxin B subunit and ApxIIA fragment, transgenic plant expressing LTB-ApxIIA fusion gene, and uses thereof

PURPOSE: A recombinant plant expression vector having a fusion protein containing E.coli endotoxin B subunit(LTB) gene and an Actinobacillus pleuropneumoniae-derived ApxIIA gene fragment is provided to effectively manufacture a vaccine for pleuropneumonia. CONSTITUTION: A recombinant plant expressio...

Full description

Saved in:
Bibliographic Details
Main Authors KIM, TAE GEUM, YANG, MOON SIK
Format Patent
LanguageEnglish
Korean
Published 12.06.2012
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:PURPOSE: A recombinant plant expression vector having a fusion protein containing E.coli endotoxin B subunit(LTB) gene and an Actinobacillus pleuropneumoniae-derived ApxIIA gene fragment is provided to effectively manufacture a vaccine for pleuropneumonia. CONSTITUTION: A recombinant plant expression vector has a fusion gene containing E.coli-derived endotoxin B subunit(LTB) gene and Actinobacillus pleuropneumoniae-derived ApxIIa gene fragment. The ApxIIA gene fragment is ApxIIA619-801 gene having a base sequence of sequence number 1. A method for preparing the LTB-ApxIIA fusion protein comprises a step of transforming a plant with a vector and expressing the fusion gene. A vaccine composition for pleuropneumonia contains LTB-ApxIIA fusion protein as an active ingredient.
Bibliography:Application Number: KR20100121786